The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Open accessAbstract
Substantial advances have been made in the treatment of chronic hepatitis B in the past decade. Approved treatments for chronic hepatitis B include 2 formulations of interferon and 4 nucleos(t)ide analogues (NAs). Sustained viral suppression is rarely achieved after withdrawal of a 48-week course of NA therapy, necessitating long, and in many cases, indefinite treatment with increasing risk of development of drug resistance. Antiviral resistance and poor adherence are the most important factors in treatment failure of hepatitis B. Thus, there is a need to standardize nomenclature relating to hepatitis B antiviral resistance, and to define genotypic, phenotypic, and clinical resistance to NA therapy. (HEPATOLOGY 2007;46:254–265.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A One-Year Trial of Lamivudine for Chronic Hepatitis B
Lai, C.-L., Chien, R.-N., Leung, N. W. Y., Chang, T.-T., Guan, R., Tai, D.-I., Ng, K.-Y., Wu, P.-C., Dent, J. C., Barber, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390201 · Cited by 1,754
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
Marcellin, P., Chang, T.-T., Lim, S. G., Tong, M. J., Sievert, W., Shiffman, M. L., Jeffers, L., Goodman, Z., Wulfsohn, M. S., Xiong, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020681 · Cited by 1,336
Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States
Dienstag, J. L., Schiff, E. R., Wright, T. L., Perrillo, R. P., Hann, H.-W. L., Goodman, Z., Crowther, L., Condreay, L. D., Woessner, M., Rubin, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411702 · Cited by 1,226
Marcellin, P., Lau, G. K. K., Bonino, F., Farci, P., Hadziyannis, S., Jin, R., Lu, Z.-M., Piratvisuth, T., Germanidis, G., Yurdaydin, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040431 · Cited by 1,145
LAMIVUDINE AS INITIAL TREATMENT FOR CHRONIC HEPATITIS B IN THE UNITED STATES
Ules, J., Ienstag, L. D., Chiff, E. U. R. S., Right, L. W., Errillo, R. O. P. P., Ann, L. H., Rowther, L. Y. C., Ondreay, D. C., Oessner, M. A. W., Ubin, M. A. R., et al. (1999) · Cited by 1,116
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
Allen, M. I., Deslauriers, M., Andrews, W. C., Tipples, G. A., Walters, K.-A., Tyrrell, D. L., Brown, N., & Condreay, L. D. (1998) · Hepatology · doi:10.1002/hep.510270628 · Cited by 793
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
Lok, A. S. F., Lai, C.-L., Leung, N., Yao, G.-B., Cui, Z.-Y., Schiff, E. R., Dienstag, J. L., Heathcote, E. J., Little, N. R., Griffiths, D. A., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.033 · Cited by 764
Self-citationLadner, S. K., Otto, M. J., Barker, C. S., Zaifert, K., Wang, G. H., Guo, J. T., Seeger, C., & King, R. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1715 · Cited by 640
Management of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Self-citationPalmer, S., Wiegand, A. P., Maldarelli, F., Bazmi, H., Mican, J. M., Polis, M., Dewar, R. L., Planta, A., Liu, S., Metcalf, J. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4531-4536.2003 · Cited by 604
Angus, P., Vaughan, R., Xiong, S., Yang, H., Delaney, W., Gibbs, C., Brosgart, C., Colledge, D., Edwards, R., Ayres, A., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00939-9 · Cited by 564
Self-citationPeters, M. G., Hann, H. W., Martin, P., Heathcote, E. J., Buggisch, P., Rubin, R., Bourliere, M., Kowdley, K., Trepo, C., Gray, D. F., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.051 · Cited by 552
Palmer, S., Kearney, M., Maldarelli, F., Halvas, E. K., Bixby, C. J., Bazmi, H., Rock, D., Falloon, J., Davey, R. T., Dewar, R. L., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.406-413.2005 · Cited by 506
Ling, R., Mutimer, D., Ahmed, M., Boxall, E. H., Elias, E., Dusheiko, G. M., & Harrison, T. J. (1996) · Hepatology · doi:10.1002/hep.510240339 · Cited by 466
LAI, C., LEUNG, N., TEO, E., TONG, M., WONG, F., HANN, H., HAN, S., POYNARD, T., MYERS, M., & CHAO, G. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.053 · Cited by 449
van Bömmel, F., Wünsche, T., Mauss, S., Reinke, P., Bergk, A., Schürmann, D., Wiedenmann, B., & Berg, T. (2004) · Hepatology · doi:10.1002/hep.20464 · Cited by 389
Yuen, M.-F., Sablon, E., Hui, C.-K., Yuan, H.-J., Decraemer, H., & Lai, C.-L. (2001) · Hepatology · doi:10.1053/jhep.2001.27563 · Cited by 386
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
Stuyver, L. (2001) · Hepatology · doi:10.1053/jhep.2001.22166 · Cited by 382
van Bömmel, F., Zöllner, B., Sarrazin, C., Spengler, U., Hüppe, D., Möller, B., Feucht, H.-H., Wiedenmann, B., & Berg, T. (2006) · Hepatology · doi:10.1002/hep.21253 · Cited by 287
Sheldon, J., Camino, N., Rodés, B., Bartholomeusz, A., Kuiper, M., Tacke, F., Núñez, M., Mauss, S., Lutz, T., Klausen, G., et al. (2005) · Antiviral Therapy · doi:10.1177/135965350501000612 · Cited by 285
Self-citationLampertico, P., Viganò, M., Manenti, E., Iavarone, M., Lunghi, G., & Colombo, M. (2005) · Hepatology · doi:10.1002/hep.20939 · Cited by 272
Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus
Delaney, W. E., Ray, A. S., Yang, H., Qi, X., Xiong, S., Zhu, Y., & Miller, M. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00138-06 · Cited by 259
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase
Zoulim, F., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.6-13.1994 · Cited by 255
Self-citationEvolution of multi-drug resistant hepatitis B virus during sequential therapy
Yim, H. J., Hussain, M., Liu, Y., Wong, S. N., Fung, S. K., & Lok, A. S. F. (2006) · Hepatology · doi:10.1002/hep.21290 · Cited by 253
Self-citationChang, T., Gish, R. G., Hadziyannis, S. J., Cianciara, J., Rizzetto, M., Schiff, E. R., Pastore, G., Bacon, B. R., Poynard, T., Joshi, S., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.055 · Cited by 246
Management of Antiviral Resistance in Patients with Chronic Hepatitis B
Locarnini, S., Hatzakis, A., Heathcote, J., Keeffe, E. B., Liang, T. J., Mutimer, D., Pawlotsky, J.-M., & Zoulim, F. (2004) · Antiviral Therapy · doi:10.1177/135965350400900522 · Cited by 237
Self-citationYang, H., Qi, X., Sabogal, A., Miller, M., Xiong, S., & Delaney, W. E. (2005) · Antiviral Therapy · doi:10.1177/135965350501000507 · Cited by 170
Lok, A. S.-F., Zoulim, F., LOCARNINI, S. A., Mangia, A., Niro, G. A., Decraemer, H., Maertens, G. G., Hulstaert, F., de Vreese, K., & Sablon, E. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3729-3734.2002 · Cited by 152
Self-citationTenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B
Kuo, A., Dienstag, J. L., & Chung, R. T. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00017-5 · Cited by 123
Comparisons of the Hbv and HIV Polymerase, and Antiviral Resistance Mutations
Bartholomeusz, A., Tehan, B. G., & Chalmers, D. K. (2004) · Antiviral Therapy · doi:10.1177/135965350400900203 · Cited by 122
Self-citationChen, R. Y. M., Edwards, R., Shaw, T., Colledge, D., Delaney, W. E., Isom, H. C., Bowden, S., Desmond, P. V., & LOCARNINI, S. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50012 · Cited by 121
Self-citationGonzales, M. J., Wu, T. D., Taylor, J., Belitskaya, I., Kantor, R., Israelski, D. M., Chou, S., Zolopa, A. R., Fessel, W. J., & Shafer, R. W. (2003) · AIDS · doi:10.1097/00002030-200304110-00003 · Cited by 107
Delaney, W. E., Edwards, R., Colledge, D., Shaw, T., Torresi, J., Miller, T. G., Isom, H. C., Bock, C. –., Manns, M. P., Trautwein, C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1705-1713.2001 · Cited by 93
Self-citationThe key lesson of family planning programmes for HIV/AIDS control
Cleland, J., & WATKINS, S. C. (2005) · AIDS · doi:10.1097/01.aids.0000194135.35758.cd · Cited by 79
Toward a Pharmacogenetic Understanding of Nucleotide and Nucleoside Analogue Toxicity
Hulgan, T., & Haas, D. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/508550 · Cited by 17
Eriksson, S., & Wang, L. (2002) · Elsevier eBooks · doi:10.1016/b978-044450951-2/50016-3 · Cited by 14
Cited by
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.010 · Cited by 2,925
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Self-citationEASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Liaw, Y.-F., & Chu, C.-M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60207-5 · Cited by 1,218
Self-citation
Metadata
- Authors
- Lok, A. S., Zoulim, F., Locarnini, S., Bartholomeusz, A., Ghany, M. G., Pawlotsky, J.-M., Liaw, Y.-F., Mizokami, M., & Kuiken, C.
- Venue
- Hepatology
- Published
- 2007-07
- Volume
- 46
- Issue
- 1
- Pages
- 254-265
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2016449892
- Cited by
- 447
- References
- 37
- FWCI
- 32.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.